Oct 5, 2026 05:07AM
Sep 24, 2026 04:19AM
Sep 18, 2026 05:20AM
Sep 17, 2026 07:46AM
Aug 26, 2026 06:43AM
Aug 24, 2026 08:03AM
Aug 17, 2026 07:12AM Spruce Biosciences, Inc. (SPRB) PT Lowered to $104 at Guggenheim
Aug 13, 2026 04:10AM
Jul 13, 2026 02:37AM
Jun 16, 2026 06:06AM
Jun 8, 2026 04:11PM
Jun 8, 2026 04:05PM
May 27, 2026 05:50AM
May 14, 2026 04:54AM Spruce Biosciences, Inc. (SPRB) PT Lowered to $150 at Citizens After Q1 Results, Model Update
May 4, 2026 08:03AM
Apr 27, 2026 09:34AM
Mar 25, 2026 05:35AM
Dec 23, 2025 06:04AM
Dec 22, 2025 06:20AM
Dec 3, 2025 06:39AM
Nov 11, 2025 04:35AM Spruce Biosciences, Inc. (SPRB) PT Raised to $259 at Citizens
Oct 28, 2025 01:54AM
Oct 21, 2025 02:38PM
Sep 15, 2025 07:02AM
Aug 14, 2025 04:00PM
Jun 12, 2025 08:17AM
Apr 23, 2025 04:27AM
Apr 15, 2025 07:02AM Spruce Biosciences (SPRB) Announces New Corporate Strategy and Acquisition of Tralesinidase Alfa for the Treatment of Sanfilippo Syndrome Type B
Dec 11, 2024 08:12AM
Dec 11, 2024 02:54AM
Dec 11, 2024 02:53AM
Dec 10, 2024 04:02PM
Dec 10, 2024 04:01PM
Dec 2, 2024 06:05AM
Aug 12, 2024 04:02PM Spruce Biosciences, Inc. (SPRB) Tops Q2 EPS by 10c
Jun 13, 2024 07:37AM

479,013 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All